Aspen Technology, Inc. -- known as AspenTech -- is a provider of software and services for the process industries headquartered in Bedford, Massachusetts. AspenTech has 30 offices around the world, on 6 continents.
Founded in 1981, AspenTech was born out a joint research project between the Massachusetts Institute of Technology (MIT) and US Department of Energy—an Advanced System for Process Engineering (ASPEN) Project.
On July 15, 2004, AspenTech was required by the Federal Trade Commission to make divestitures in regard to an anti-trust ruling against its acquisition of HyproTech. This included divestment of batch and continuous simulation systems and integrated engineering software business (AXSYS). In the same year, a class action lawsuit was filed against Aspen Technology and its certain officers over issuance of misleading statements and improper revenue recognition.
On November 24, 2004, the company restated results for the fiscal years ended June 2000 through June 2004 after its audit committee discovered the company improperly accounted for certain software licenses. On March 15, 2005, the company announced that the Audit Committee of the Company's Board of Directors had completed its previously announced financial review and the company had restated its financials for each of the fiscal years ended June 30, 2000 through June 30, 2004.
Aspen Technology was delisted from the NASDAQ on February 19, 2008 for failing to meet financial transparency guidelines of the NASDAQ exchange. In February, 2010 the company was relisted on the NASDAQ exchange.
Under former CEO Mark Fusco, AspenTech executed a corporate turnaround strategy. Examples of steps taken during this period included:
On April 30, 2013, AspenTech announced that Mark Fusco would retire as President & CEO effective September 30, 2013. On October 1, 2013, Antonio Pietri became AspenTech President & CEO.
Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q1 2023 | 2022-10-25 | Future report Set alerts | |
Q4 2022 | 2022-08-08 | 2.43 | 2.43 |
Q3 2022 | 2022-04-27 | 1.38 | 1.38 |
Q2 2022 | 2022-01-26 | 1.20 | 1.20 |
Q1 2022 | 2021-10-27 | 0.77 | 0.77 |
Q4 2021 | 2021-08-11 | 1.53 | 1.53 |
Q3 2021 | 2021-04-28 | 1.05 | 1.05 |
Q2 2021 | 2021-01-27 | 2.04 | 2.04 |
Q1 2021 | 2020-10-28 | 0.00 | 0.00 |
Q4 2020 | 2020-08-12 | 1.54 | 1.43 |
2016-06-05 | Reiterated Rating | KeyBanc | Buy | $45.00 |
2016-06-05 | Reiterated Rating | KeyCorp | Buy | $45.00 |
2016-04-29 | Initiated Coverage | JPMorgan Chase & Co. | Underweight | $36.00 |
2016-04-26 | Boost Price Target | Benchmark Co. | Hold | $28.00 to $34.00 |
2016-03-07 | Reiterated Rating | Canaccord Genuity | Hold | $33.00 |
2016-02-17 | Reiterated Rating | Canaccord Genuity | Hold | $33.00 |
2016-02-09 | Initiated Coverage | Avondale Partners | Market Perform | $36.00 |
2016-01-29 | Lower Price Target | Pacific Crest | $50.00 to $45.00 | |
2016-01-29 | Lower Price Target | Benchmark Co. | Hold | $34.00 to $28.00 |
2016-01-29 | Lower Price Target | Canaccord Genuity | Hold | $39.00 to $33.00 |
2016-01-13 | Reiterated Rating | Canaccord Genuity | Hold | $39.00 |
2016-01-13 | Downgrade | Benchmark Co. | Buy to Hold | $45.00 to $34.00 |
2015-10-30 | Reiterated Rating | Canaccord Genuity | Hold | $39.00 |
2015-09-16 | Reiterated Rating | Pacific Crest | Overweight | $50.00 |
2015-09-10 | Reiterated Rating | William Blair | Buy | |
2015-08-14 | Reiterated Rating | Canaccord Genuity | Hold | $39.00 |
2015-08-14 | Lower Price Target | Benchmark Co. | Buy | $45.00 |
2015-05-15 | Upgrade | KeyBanc | Overweight | $50.00 |
2015-05-04 | Reiterated Rating | JPMorgan Chase & Co. | Underweight | $36.00 to $39.00 |
2015-04-29 | Reiterated Rating | Canaccord Genuity | Buy | $37.00 to $39.00 |
2015-03-19 | Initiated Coverage | Evercore ISI | Buy | $45.00 |
2015-01-22 | Downgrade | JPMorgan Chase & Co. | Neutral to Underweight | $46.50 to $36.00 |
2014-10-29 | Downgrade | Pacific Crest | Outperform to Sector Perform | |
2014-10-29 | Downgrade | Canaccord Genuity | Buy to Hold | $52.00 to $42.00 |
2014-05-19 | Downgrade | Summit Research | Buy to Hold | |
2014-04-30 | Reiterated Rating | JPMorgan Chase & Co. | Neutral | $46.50 |
2014-04-30 | Upgrade | Summit Research | Hold to Buy | $45.00 |
2014-01-31 | Boost Price Target | Benchmark Co. | $40.00 to $50.00 | |
2014-01-31 | Boost Price Target | Pacific Crest | $43.00 to $50.00 | |
2014-01-31 | Boost Price Target | Canaccord Genuity | Buy | $50.00 to $52.00 |
2014-01-17 | Boost Price Target | Canaccord Genuity | Buy | $42.00 to $50.00 |
2013-11-19 | Downgrade | Cross Research | Buy to Hold | |
2013-11-08 | Boost Price Target | Cowen and Company | Outperform | $38.00 to $42.00 |
2013-10-30 | Boost Price Target | Canaccord Genuity | Buy | $40.00 to $42.00 |
2013-10-18 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | $36.00 to $38.00 |
2013-10-01 | Boost Price Target | Benchmark Co. | Buy | $38.00 to $40.00 |
2013-08-16 | Reiterated | The Benchmark Company | Buy | $35 to $38 |
2013-05-01 | Reiterated | The Benchmark Company | Buy | $33 to $35 |
2013-01-03 | Reiterated | The Benchmark Company | Buy | $27 to $33 |
2012-08-22 | Reiterated | The Benchmark Company | Buy | $25 to $27 |
2012-04-03 | Initiated | Brigantine | Buy | $23 |
2011-02-17 | Initiated | Davenport | Buy | $22 |
2010-10-04 | Initiated | William Blair | Outperform |
2016-06-05 | Reiterated Rating | KeyBanc | Buy | $45.00 |
2016-06-05 | Reiterated Rating | KeyCorp | Buy | $45.00 |
2016-04-29 | Initiated Coverage | JPMorgan Chase & Co. | Underweight | $36.00 |
2016-04-26 | Boost Price Target | Benchmark Co. | Hold | $28.00 to $34.00 |
2016-03-07 | Reiterated Rating | Canaccord Genuity | Hold | $33.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In AZPN 267 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Inc. | 3.28M |
WADDELL & REED FINANCIAL INC | 3.24M |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 3.07M |
Vanguard Group, Inc | 2.78M |
BlackRock Fund Advisors | 2.51M |
FMR LLC | 2.22M |
BlackRock Institutional Trust Company, N.A. | 2.21M |
FRANKLIN RESOURCES INC | 0.99M |
Neuberger Berman Group LLC | 0.98M |
NORDEA INVESTMENT MANAGEMENT AB | 0.95M |
JANUS CAPITAL MANAGEMENT LLC | 0.81M |
STATE STREET CORP | 0.77M |
BAMCO INC /NY/ | 0.58M |
Jackson Square Partners, LLC | 0.56M |
LORD, ABBETT & CO. LLC | 0.55M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
Pietri Antonio J EVP, Field Operations | 0.26% (243081) | AZPN / |
FUSCO MARK President & CEO | 0.25% (225787) | AZPN / EXA / |
KOTZABASAKIS MANOLIS E EVP, Products | 0.07% (68504) | AZPN / |
Sullivan Mark P. EVP & CFO | 0.06% (53290) | AZPN / |
Griffin William EVP, Field Operations | 0.05% (45122) | AZPN / |
Johnsen Karl E Senior Vice President and CFO | 0.04% (32407) | AVID / AZPN / |
MCARDLE JOAN C | 0.03% (29792) | AZPN / DWCH / |
Hammond F G SVP & General Counsel | 0.02% (21568) | AZPN / |
GANN SIMON OREBI | 0.02% (18300) | AZPN / |
HAROIAN GARY E | 0.01% (13583) | ANET / AZPN / BCOV / ENOC / |
Whelan, Jr. Robert M. | 0.01% (11887) | ARIA / AZPN / |
CASEY DONALD P | 0.01% (6924) | AZPN / |